At recent prices, the yield you receive from Pfizer is more than four times the amount you'd receive from the average ...

Pfizer exec Philip Dormitzer amid claims the COVID-19 vaccine announcement was delayed to avoid influencing the 2020 election ...

Despite recent declines, we believe Pfizer stock is a compelling buy right now, with its current price of around $23 likely reflecting existing concerns.

Pfizer Inc. (PFE), headquartered in New York, discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products. With a market cap of $134.9 billion, the company offers ...

In this article, we are going to take a look at where Pfizer Inc. (NYSE:PFE) stands against other safe stocks to buy for the long term in 2025. The US stock market is often regarded as one of […] ...

Regardless of which you choose, Pfizer's (NYSE: PFE) share price has declined during the period. Pfizer's dismal stock performance in recent years underscores the challenges the big drugmaker faces.

New York-based Pfizer PFE had net income of $41 million, or 1 cent a share, for the quarter, down from $2.327 billion, or 41 cents a share, in the year-earlier period. Partner Center Most Popular ...

The Texas Stock Exchange is looking to steal New York’s crown as the center of U.S. capital markets. It has a powerful force behind it: red-state frustration with the perceived liberal agenda of ...

PFE is a Zacks Rank #3 (Hold) stock, with a Value Style Score of B and VGM Score of B. Shares are currently trading at a forward P/E of 10.7X for the current fiscal year compared to the Large Cap ...

With a market cap of $144.8 billion, New York-based Pfizer Inc. (PFE) is a global biopharmaceutical company that discovers, develops, and markets innovative medicines and vaccines across diverse ...

Former Pfizer executives Ian Read and Frank D’Amelio have decided “not to be involved” in Starboard Value’s activist campaign against the drug company, according to a statement released on ...